CD274 and neoplasm: The construction of the anti-PD-L1 (programmed cell death ligand 1) antibodies and PE38 expression system in the Nissle 1917 strain has demonstrated superior suppression effects in mouse subcutaneous tumor models via intravenous injection (Li et al., 2025).